Yerbamate Tea Consumption: A Protective Factor in Parkinson Disease

Sáenz-Farret M.; Salinas-Martínez A.M.; Zúñiga-Ramírez C.; Amorín-Costábile I.; Maiola R.; Mejía-Rojas K.K.; Galeano M.S.; Velázquez C.; Ruiz G.; Micheli F. · Clinical Neuropharmacology (2022) · DOI: 10.1097/wnf.0000000000000513

Resumen

Introduction Little is known about the association between Yerbamate (YMT) tea consumption and Parkinson disease (PD). We determined whether there was an association between YMT tea consumption and PD. Methods We conducted a multicenter case-control study in 3 countries (Argentina, Paraguay, and Uruguay). We applied a structured questionnaire about YMT tea consumption history. The survey also included information about factors previously associated with a decreased and increased risk of PD, apart from medical and demographic factors. Odds ratios and 95% confidence intervals were calculated using multivariate unconditional binary logistic regression analysis. Results We included 215 cases and 219 controls. The mean age of the cases was 65.6 ± 10.5 years and that of controls was 63.1 ± 10.5 years (P < 0.02). Years of YMT tea consumption, number of liters drunk per day, and amount of YMT used for preparing the infusion were similar between cases and controls (P > 0.05), but not the number of times the YMT was added into the container (P = 0.003) and the YMT tea concentration per serving (P = 0.02). The multivariate analysis showed that YMT tea concentration per serving lowered the risk for PD, independent of potential confounders (odds ratio, 0.62; 95% confidence interval, 0.47-0.84). Conclusions This multicenter study highlights the association between an environmental factor, the YMT tea drinking, and PD. Although more evidence from longitudinal studies is needed, the results obtained here points toward a protective effect of the YMT tea concentration per serving on PD. © Wolters Kluwer Health, Inc. All rights reserved.

Instituciones: Universidad Nacional Mayor de San Marcos